{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:22:36Z","timestamp":1790342556335,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To evaluate the long-term efficacy of an 8-week regimen of pelvic floor muscle training guided by a motion-based digital therapeutic device compared with a standard home program in the treatment of stress urinary incontinence (SUI) and stress-predominant mixed urinary incontinence (MUI).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>The primary virtual trial was conducted from October 2020 to March 2021; 363 women with SUI or stress-predominant MUI were randomized to complete pelvic floor muscle training using the device (intervention group) or a standard home pelvic floor muscle training program (control group) for 8 weeks. Primary outcomes included change in UDI-6 (Urogenital Distress Inventory, Short Form) score and SUI episodes on a 3-day bladder diary. The PGI-I (Patient Global Impression of Improvement) was also assessed, with \u201cmuch better\u201d and \u201cvery much better\u201d responses considered as improvement. In this planned secondary analysis, symptom and adherence data were collected in follow-up at 6 and 12 months. A modified intention-to-treat analysis was performed using Student's <jats:italic toggle=\"yes\">t<\/jats:italic> tests and \u03c7<jats:sup>2<\/jats:sup> tests as appropriate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Of 299 participants analyzed at 8 weeks, 286 (95.7%) returned 6- and 12-month data (151 in the control group, 135 in the intervention group). Mean age was 51.9\u00b112.8 years, and mean body mass index (BMI) was 31.8\u00b17.4; 84.6% of participants were parous, and 54.9% were postmenopausal. Mean change in UDI-6 score from baseline to 6 and 12 months was significantly greater in the intervention group than in the control group (20.2\u00b120.9 vs 14.8\u00b119.5, <jats:italic toggle=\"yes\">P<\/jats:italic>=.03 and 22.7\u00b123.3 vs 15.9\u00b120.3, <jats:italic toggle=\"yes\">P<\/jats:italic>=.01, respectively). Participants in the intervention group had more than twice the odds of reporting improvement on the PGI-I compared with participants in the control group (OR 2.45, 95% CI 1.49\u20134.00).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Pelvic floor muscle training guided by a motion-based digital therapeutic device yielded significantly greater urinary incontinence symptom improvement compared with a standard home pelvic floor muscle training program at 6 and 12 months, although continued improvement waned over time. This technology may facilitate pelvic floor muscle training access and adherence for women with SUI and stress-predominant MUI and represents an effective modality for scaling first-line care.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>FUNDING SOURCE:<\/jats:title>\n            <jats:p>Renovia Inc.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n            <jats:p>\n                                 ClinicalTrials.gov, NCT04508153.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000005036","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T22:02:40Z","timestamp":1671141760000},"page":"199-206","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Digital Therapeutic Device for Urinary Incontinence"],"prefix":"10.1097","volume":"141","author":[{"given":"Milena M.","family":"Weinstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gena C.","family":"Dunivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelani M.","family":"Guaderrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly E.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,11,30]]},"reference":[{"key":"R1-20250423","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/SPV.0000000000001127","article-title":"Updated prevalence of urinary incontinence in women: 2015-2018 national population-based survey data","volume":"28","author":"Patel","year":"2022","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"R2-20250423","doi-asserted-by":"crossref","first-page":"101842","DOI":"10.1016\/j.jogoh.2020.101842","article-title":"Systematic review of guidelines for urinary incontinence in women","volume":"49","author":"Favre-Inhofer","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"R3-20250423","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/jwh.2021.0266","article-title":"Female urinary incontinence evidence-based treatment pathway: an infographic for shared decision-making","volume":"31","author":"McKinney","year":"2022","journal-title":"J Women's Health"},{"key":"R4-20250423","first-page":"CD005654","article-title":"Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women","volume":"10","author":"Dumoulin","year":"2018","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R5-20250423","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/GME.0000000000000943","article-title":"Factors associated with reasons incontinent midlife women report for not seeking urinary incontinence treatment over 9 years across the menopausal transition","volume":"25","author":"Waetjen","year":"2018","journal-title":"Menopause"},{"key":"R6-20250423","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11934-015-0572-0","article-title":"Pelvic floor muscle training: underutilization in the USA","volume":"17","author":"Lamin","year":"2016","journal-title":"Curr Urol Rep"},{"key":"R7-20250423","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/nau.24256","article-title":"Implementing pelvic floor muscle training in women's childbearing years: a critical interpretive synthesis of individual, professional, and service issues","volume":"39","author":"Salmon","year":"2020","journal-title":"Neurourol Urodyn"},{"key":"R8-20250423","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/nau.22771","article-title":"Pelvic floor muscle training adherence \u201cmodifiers\u201d: a review of primary qualitative studies - 2011 ICS state-of-the-science seminar research paper III of IV","volume":"34","author":"Hay-Smith","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"R9-20250423","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/nau.24913","article-title":"Retrospective claims analysis of physical therapy utilization among women with stress or mixed urinary incontinence","volume":"41","author":"McKinney","year":"2022","journal-title":"Neurourol Urodyn"},{"key":"R10-20250423","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00192-019-04012-w","article-title":"Mobile technologies for the conservative self-management of urinary incontinence: a systematic scoping review","volume":"31","author":"Bernard","year":"2020","journal-title":"Int Urogynecol J"},{"key":"R11-20250423","first-page":"606","article-title":"Digital therapeutic device for urinary incontinence","volume":"139","author":"Weinstein","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R12-20250423","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/cpt.1036","article-title":"Digital therapeutics: an integral component of digital innovation in Drug development","volume":"104","author":"Sverdlov","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"R13-20250423","doi-asserted-by":"crossref","first-page":"106406","DOI":"10.1016\/j.cct.2021.106406","article-title":"Randomized trial comparing efficacy of pelvic floor muscle training with a digital therapeutic motion-based device to standard pelvic floor exercises for treatment of stress urinary incontinence (SUV trial): an all-virtual trial design","volume":"105","author":"Weinstein","year":"2021","journal-title":"Contemp Clin Trials"},{"key":"R15-20250423","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2004.12.025","article-title":"Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7)","volume":"193","author":"Barber","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R16-20250423","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.ajog.2009.02.007","article-title":"The minimum important differences for the urinary scales of the pelvic floor distress inventory and Pelvic Floor Impact Questionnaire","volume":"200","author":"Barber","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R17-20250423","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/nau.20934","article-title":"Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ)","volume":"30","author":"Barber","year":"2011","journal-title":"Neurourol Urodyn"},{"issue":"suppl 3","key":"R18-20250423","doi-asserted-by":"crossref","first-page":"iii40","DOI":"10.1136\/ard.2007.079798","article-title":"Minimal clinically important improvement\/difference (MCII\/MCID) and Patient Acceptable Symptom State (PASS): what do these concepts mean?","volume":"66","author":"Kvien","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R19-20250423","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/art.22110","article-title":"Feeling good rather than feeling better matters more to patients","volume":"55","author":"Tubach","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R20-20250423","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/SPV.0000000000001055","article-title":"The Patient Acceptable Symptom State in female urinary incontinence","volume":"28","author":"Sanderson","year":"2022","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"R21-20250423","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/GME.0000000000000594","article-title":"Physical therapy for urinary incontinence in postmenopausal women with osteoporosis or low bone density: a randomized controlled trial","volume":"23","author":"Sran","year":"2016","journal-title":"Menopause"},{"key":"R22-20250423","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/aogs.13192","article-title":"Self-management of stress urinary incontinence via a mobile app: two-year follow-up of a randomized controlled trial","volume":"96","author":"Hoffman","year":"2017","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T18:01:37Z","timestamp":1745431297000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005036"}},"subtitle":["A Longitudinal Analysis at 6 and 12 Months"],"short-title":[],"issued":{"date-parts":[[2022,11,30]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005036","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,30]]},"assertion":[{"value":"2022-10-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}